Markus Augusti, president and CEO of orthopedics implant company Conformis, told investors during the J.P. Morgan Healthcare conference that the company is executing on its strategic pivot, announced in August, to develop and market “less-personalized” hip and knee products for treating patients in ambulatory care centers.
The trend toward moving knee and hip surgeries into the outpatient setting has been going on for some time. The...